Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MEDICLOCK HEALTHCARE PRIVATE LIMITED | 5 | ₹752.40 |
| 2 | Schedule 2 | PARAMOUNT MEDICAL AGENCIES | 5 | ₹1,712.70 |
| 3 | Schedule 3 | SAI KRISHNA AGENCIES | 1 | ₹6,552 |
| 4 | Schedule 4 | SAI KRISHNA AGENCIES | 1 | ₹4,536 |
| 5 | Schedule 5 | PARAMOUNT MEDICAL AGENCIES | 1 | ₹54,435 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
3 Nov 2023, 2:00 pmClosed
LP OF 05 DRUGS FOR ECHS
5494559
GEM/2023/B/4116429
Two Packet Bid
Letrazole,MirabegronSolifinacin,DolutegravirEmtrictabineTenofovir,TenofovirLamivudineDolutegravir,T
15 days
Andhra Pradesh; Visakhapatanam
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹31
60%
Exempted
10 Nov 2023
20 Oct 2023
3 Nov 2023
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Letrazole | Tab Letrazole 2.5mg | 90 | No | Visakhapatnam | 15 |
| 2 | MirabegronSolifinacin | Tab Mirabegron 25mg + solifinacin 5mg | 90 | No | Visakhapatnam | 15 |
| 3 | DolutegravirEmtrictabineTenofovir | Tab Dolutegravir 50mg + Emtrictabine 200mg + Tenofovir Alfinamide 25mg | 90 | No | Visakhapatnam | 15 |
| 4 | TenofovirLamivudineDolutegravir | Tab Tenofovir 300mg + Lamivudine 300mg + Dolutegravir 50mg | 90 | No | Visakhapatnam | 15 |
| 5 | Tocilizumab | Inj Tocilizumab 162mg | 3 | No | Visakhapatnam | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5494559.pdf
GEM_BID
bbqr_2023-10-20-12-55-30_c8f1d3b0936a5d62eb9310e2e8c07f51.pdf
BOQ
boqec_2023-10-20-12-55-30_123fcc207463d04ced913f58882289e6.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .